Holdings of HARTFORD HEALTHCARE HLS FUND
HARTFORD SERIES FUND INC · Original filing · Compare with another fund · Report an error
- Net assets
- 104.5M $ including 103.8M $ in equities, 99.4 %
- Positions
- 83 in 9 countries
- Top ten
- 46.6 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 13,727 | 12.6M $ | 12.09 % |
| 2 | Merck & Co Inc | 58,295 | 7M $ | 6.71 % |
| 3 | Johnson & Johnson | 25,836 | 6.3M $ | 6.05 % |
| 4 | UnitedHealth Group Inc | 15,880 | 4.3M $ | 4.11 % |
| 5 | Intuitive Surgical Inc | 8,008 | 3.7M $ | 3.53 % |
| 6 | AbbVie Inc | 15,306 | 3.3M $ | 3.19 % |
| 7 | Abbott Laboratories | 29,323 | 3M $ | 2.88 % |
| 8 | Danaher Corp | 15,625 | 3M $ | 2.84 % |
| 9 | Edwards Lifesciences Corp | 35,612 | 2.9M $ | 2.73 % |
| 10 | Vertex Pharmaceuticals Inc | 5,853 | 2.6M $ | 2.50 % |
| 11 | Boston Scientific Corp | 36,858 | 2.3M $ | 2.21 % |
| 12 | CVS Health Corp | 30,494 | 2.2M $ | 2.10 % |
| 13 | Cencora Inc | 6,558 | 2.1M $ | 1.97 % |
| 14 | Regeneron Pharmaceuticals, Inc. | 2,529 | 2M $ | 1.87 % |
| 15 | HCA Healthcare Inc | 4,101 | 1.9M $ | 1.86 % |
| 16 | Thermo Fisher Scientific Inc | 3,624 | 1.8M $ | 1.71 % |
| 17 | Elevance Health Inc | 5,698 | 1.7M $ | 1.60 % |
| 18 | Medtronic PLC | 17,484 | 1.5M $ | 1.45 % |
| 19 | Cardinal Health, Inc. | 6,868 | 1.5M $ | 1.39 % |
| 20 | GSK PLC | 51,586 | 1.4M $ | 1.36 % |
| 21 | Agilent Technologies Inc | 11,491 | 1.3M $ | 1.25 % |
| 22 | United Therapeutics Corp | 2,174 | 1.3M $ | 1.23 % |
| 23 | Stryker Corp | 3,578 | 1.2M $ | 1.13 % |
| 24 | Argenx SE | 1,529 | 1.1M $ | 1.07 % |
| 25 | UCB SA | 3,637 | 1.1M $ | 1.05 % |
| 26 | Dexcom Inc | 16,874 | 1.1M $ | 1.01 % |
| 27 | Biogen Inc | 5,481 | 1M $ | 0.96 % |
| 28 | Apellis Pharmaceuticals Inc | 23,638 | 951K $ | 0.91 % |
| 29 | STERIS PLC | 4,043 | 894K $ | 0.86 % |
| 30 | Ionis Pharmaceuticals Inc | 11,237 | 843.8K $ | 0.81 % |
| 31 | Incyte Corp | 8,743 | 822.9K $ | 0.79 % |
| 32 | Alnylam Pharmaceuticals Inc | 2,464 | 815.3K $ | 0.78 % |
| 33 | Madrigal Pharmaceuticals Inc | 1,536 | 804K $ | 0.77 % |
| 34 | Ascendis Pharma A/S | 3,460 | 791.4K $ | 0.76 % |
| 35 | Bristol-Myers Squibb Co | 12,812 | 777K $ | 0.74 % |
| 36 | Elanco Animal Health Inc | 31,004 | 741.9K $ | 0.71 % |
| 37 | Galderma Group AG | 3,695 | 726.2K $ | 0.70 % |
| 38 | Cytokinetics Inc | 10,815 | 712.8K $ | 0.68 % |
| 39 | Encompass Health Corp | 6,943 | 671.6K $ | 0.64 % |
| 40 | Protagonist Therapeutics Inc | 6,317 | 665.8K $ | 0.64 % |
| 41 | Revolution Medicines Inc | 6,612 | 643K $ | 0.62 % |
| 42 | Bio-Techne Corp | 12,008 | 627.5K $ | 0.60 % |
| 43 | Disc Medicine Inc | 9,537 | 609.8K $ | 0.58 % |
| 44 | Alignment Healthcare Inc | 34,524 | 608.3K $ | 0.58 % |
| 45 | Pharvaris NV | 21,196 | 598.8K $ | 0.57 % |
| 46 | HeartFlow Inc | 24,312 | 591.5K $ | 0.57 % |
| 47 | Option Care Health Inc | 20,393 | 549K $ | 0.53 % |
| 48 | Scholar Rock Holding Corp | 10,864 | 534.1K $ | 0.51 % |
| 49 | ICON PLC | 4,813 | 532.6K $ | 0.51 % |
| 50 | Apogee Therapeutics Inc | 6,243 | 525.5K $ | 0.50 % |
| 51 | Avantor Inc | 66,012 | 517.5K $ | 0.50 % |
| 52 | Dianthus Therapeutics Inc | 6,126 | 514.1K $ | 0.49 % |
| 53 | Kymera Therapeutics Inc | 6,039 | 503K $ | 0.48 % |
| 54 | PTC Therapeutics Inc | 7,369 | 502K $ | 0.48 % |
| 55 | Mirum Pharmaceuticals Inc | 5,399 | 498.8K $ | 0.48 % |
| 56 | Structure Therapeutics Inc | 10,133 | 488.4K $ | 0.47 % |
| 57 | Arcus Biosciences Inc | 22,493 | 485.8K $ | 0.47 % |
| 58 | Natera Inc | 2,394 | 478.8K $ | 0.46 % |
| 59 | Viridian Therapeutics Inc | 24,390 | 477.1K $ | 0.46 % |
| 60 | QIAGEN NV | 11,870 | 475.3K $ | 0.46 % |
| 61 | Oculis Holding AG | 17,442 | 463.8K $ | 0.44 % |
| 62 | Xenon Pharmaceuticals Inc | 7,624 | 443.3K $ | 0.42 % |
| 63 | Acadia Healthcare Co Inc | 18,573 | 434.4K $ | 0.42 % |
| 64 | Adaptive Biotechnologies Corp | 30,861 | 428.4K $ | 0.41 % |
| 65 | AstraZeneca PLC | 2,167 | 427.4K $ | 0.41 % |
| 66 | Nuvalent Inc | 4,103 | 420.4K $ | 0.40 % |
| 67 | Celldex Therapeutics Inc | 12,569 | 398.7K $ | 0.38 % |
| 68 | Vaxcyte Inc | 6,840 | 397.5K $ | 0.38 % |
| 69 | Mineralys Therapeutics Inc | 14,421 | 390.7K $ | 0.37 % |
| 70 | Soleno Therapeutics Inc | 11,658 | 390.3K $ | 0.37 % |
| 71 | GenFleet Therapeutics Shanghai Inc | 91,400 | 389.6K $ | 0.37 % |
| 72 | Inspire Medical Systems Inc | 7,432 | 383.3K $ | 0.37 % |
| 73 | Jiangsu Hengrui Pharmaceuticals Co Ltd | 45,725 | 380.7K $ | 0.36 % |
| 74 | Immunocore Holdings PLC | 12,125 | 365.6K $ | 0.35 % |
| 75 | Immunome Inc | 16,589 | 362.8K $ | 0.35 % |
| 76 | Stoke Therapeutics Inc | 10,840 | 353K $ | 0.34 % |
| 77 | Trevi Therapeutics Inc | 28,925 | 345.1K $ | 0.33 % |
| 78 | Crinetics Pharmaceuticals Inc | 8,142 | 295.7K $ | 0.28 % |
| 79 | Aktis Oncology Inc | 14,533 | 260K $ | 0.25 % |
| 80 | Newamsterdam Pharma Co NV | 7,683 | 245.9K $ | 0.24 % |
| 81 | CG oncology Inc | 1,875 | 126.9K $ | 0.12 % |
| 82 | Corvus Pharmaceuticals Inc | 4,000 | 58.5K $ | 0.06 % |
| 83 | Eikon Therapeutics Inc | 2,100 | 22.2K $ | 0.02 % |
Sector breakdown
- Health care 77.0 %
- Unattributed 23.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 96.1 %
- GBP 1.4 %
- EUR 1.1 %
- HKD 0.7 %
- CHF 0.7 %
The quoted currency of each line, as declared.
Country breakdown
- United States 91.7 %
- Netherlands 1.9 %
- United Kingdom 1.8 %
- Switzerland 1.1 %
- Belgium 1.1 %
- Denmark 0.8 %
- Hong Kong SAR China 0.7 %
- Ireland 0.5 %
- Canada 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 70 | 95.2M $ | 91.68 % |
| 2 | Netherlands | 3 | 2M $ | 1.89 % |
| 3 | United Kingdom | 2 | 1.8M $ | 1.78 % |
| 4 | Switzerland | 2 | 1.2M $ | 1.15 % |
| 5 | Belgium | 1 | 1.1M $ | 1.06 % |
| 6 | Denmark | 1 | 791.4K $ | 0.76 % |
| 7 | Hong Kong SAR China | 2 | 770.3K $ | 0.74 % |
| 8 | Ireland | 1 | 532.6K $ | 0.51 % |
| 9 | Canada | 1 | 443.3K $ | 0.43 % |
Cite this page
Titelia. "Holdings of HARTFORD HEALTHCARE HLS FUND". https://titelia.com/en/funds/S000003206